A Global, Multicenter, Open-label, Single Agent, Two-stage Phase 2 Study to Evaluate the Efficacy and Safety of AMG 102 in Subjects With Advanced Renal Cell Carcinoma

Update Il y a 5 ans
Reference: EUCTR2006-003785-33

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess objective response rate in subjects with advanced renal cell carcinoma receiving AMG 102 treatment.


Inclusion criteria

  • ADVANCED RENAL CELL CARCINOMA

Links